Pages Tagged with "Phase 1 Clinical Trial"

CAR T cell therapy trial targets advanced ovarian cancer
Very few effective treatment options are available for patients with recurrent ovarian cancer and other solid tumors, but researchers are trying to change that.  Saul Priceman, Ph.D.Scientists at City of Hope recently...
City of Hope researchers develop a CAR T cell therapy for advanced ovarian cancer
LOS ANGELES — There are currently few effective treatment options for patients with recurrent ovarian cancer and other solid tumors, but City of Hope researchers are trying to change that. ...
City of Hope and Calidi Biotherapeutics announce first patient dosed in a Phase 1 clinical trial evaluating neural stem cells engineered to carry an oncolytic virus, CLD-101, in recurrent high-grade glioma patients
For Media: City of Hope Letisia Marquez lemarquez@coh.org (626) 476-7593 Calidi Biotherapeutics Stephen Thesing Sthesing@calidibio.com  (858) 794-9600 For Investors: Gilmartin Group Stephen Jasper stephen@gilmartinir.com  LOS ANGELES and SAN DIEGO, Calif. ...
City of Hope and Osel announce live biotherapeutic product CBM588 may enhance efficacy of immunotherapy for patients with metastatic kidney cancer
  CONTACT City of Hope Zen Vuong 626-409-9367zvuong@coh.org   CONTACT for Osel Michelle Linn Bioscribe 774-696-3803michelle@bioscribe.com   Additional Phase 1 clinical trial of CBM588 plus immune checkpoint and...
Data published in a Lancet journal on COH04S1, a City of Hope-developed COVID-19 vaccine, shows it produced robust antibodies and T cells against SARS-CoV-2
MEDIA CONTACT Letisia Marquez 626-218-3398lemarquez@coh.org The investigational vaccine is now being used in Phase 2 trials for immunocompromised patients and as a booster for healthy adult volunteers.   LOS...
City of Hope opens first multiple myeloma autologous CAR T cell therapy trial targeting CS1 protein on cancer cells
CONTACTLetisia Marquez626-218-3398lemarquez@coh.org City of Hope will manufacture CAR T cells in its own laboratories DUARTE, Calif. — City of Hope is now enrolling patients with...
City of Hope and Mustang Bio Announce First Patient Dosed in Phase 1 Clinical Trial of MB-101 (IL13Rα2-specific CAR T cells) to Treat Leptomeningeal Brain Tumors
City of Hope Contact Letisia Marquez City of Hope (626) 476-7593 lemarquez@coh.org   Mustang Bio Inc. Contact: Jaclyn Jaffe and Bill Begien Mustang Bio Inc. (781) 652-4500 ir@mustangbio.com   Investor Relations...
Subscribe to Phase 1 Clinical Trial